ReviewCancers2021

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?

Christian Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.